Evidence map›Paper›PMID 26966089›Full record

ReviewBlood2016

Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages.

Jean-François Emile, Oussama Abla, Sylvie Fraitag, Annacarin Horne, Julien Haroche, Jean Donadieu, Luis Requena-Caballero, Michael B Jordan, Omar Abdel-Wahab, Carl E Allen and 15 more

Open access · bronzeAbstract readReview
In one paragraph

Review in Blood, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 648 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
648citing papers in PubMed, 3 pooled it
73.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

648 citing papers in PubMed, 3 syntheses or guidelines pooled it, 1,526 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Head and neck rosai-dorfman disease: upper airway predominance in 42 patients.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2026
    Article
  10. Review
  11. Basic Principles of Skin Biopsy Optimization in Dermatopathology.Dermatopathology (Basel, Switzerland) · 2026
    Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Article
  18. Article
  19. [Infant with nodular cutaneous lesions on the torso and head].Dermatologie (Heidelberg, Germany) · 2026
    Article
  20. Article

588 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

25 authors at 18 institutions in 5 countries.

Jean-François EmileResearch Unit EA4340, Versailles University, Paris-Saclay University, Boulogne, France; Pathology Department, Ambroise Paré Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Boulogne, France;ORCID 0000-0002-6073-4466
Oussama AblaDivision of Hematology/Oncology, Department of Pediatrics, The Hospital for Sick Children, University of Toronto, Toronto, ON, Canada;
Sylvie FraitagPathology Department, Necker Hospital, Paris, France;
Annacarin HorneDepartment of Women's and Children's Health, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden;
Julien HarocheDepartment of Internal Medicine and French Reference Center for Rare Auto-immune and Systemic Diseases, Institut E3M, AP-HP, Pitié-Salpêtrière Hospital, Paris, France; Université Pierre et Marie Curie University Paris 6, Paris, France;
Jean DonadieuResearch Unit EA4340, Versailles University, Paris-Saclay University, Boulogne, France; Pediatric Hematology, Trousseau Hospital, APHP, Paris, France;
Luis Requena-CaballeroFundación Jiménez Díaz, Universidad Autónoma, Madrid, Spain;
Michael B JordanDepartment of Pediatrics, Cincinnati Children's Hospital Medical Center and the University of Cincinnati College of Medicine, Cincinnati, OH;
Omar Abdel-WahabLeukemia Service, Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY;
Carl E AllenFeigin Center, Texas Children's Cancer Center, Houston, TX;
Frédéric CharlotteUniversité Pierre et Marie Curie University Paris 6, Paris, France; Pathology Department, Pitié-Salpétrière Hospital, Paris, France;
Eli L DiamondDepartment of Neurology, Memorial Sloan Kettering Cancer Center, New York, NY;
R Maarten EgelerDivision of Hematology/Oncology, Department of Pediatrics, The Hospital for Sick Children, University of Toronto, Toronto, ON, Canada;
Alain FischerNecker Enfants Malades Hospital, AP-HP, Paris, France; Institut Imagine, Sorbonne Paris Cité, Université Paris Descartes, Paris, France;
Juana Gil HerreraDivision of Clínical Immunology, Hospital General Universitario and Health Research Institute "Gregorio Marañón," Madrid, Spain;
Jan-Inge HenterChildhood Cancer Research Unit, Department of Women's and Children's Health, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden;
Filip JankuDepartment of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, TX;
Miriam MeradMount Sinai School of Medicine, New York, NY;
Jennifer PicarsicPathology Department, University of Pittsburgh School of Medicine, Children's Hospital of Pittsburgh of University of Pittsburgh Medical Center, Pittsburgh, PA;
Carlos Rodriguez-GalindoDana-Farber Cancer Institute, Boston, MA;
Barret J RollinsDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA; Department of Medicine, Brigham & Women's Hospital, Harvard Medical School, Boston, MA;
Abdellatif TaziDivision of Pulmonary, Saint Louis Hospital, Paris, France;
Robert VassalloDivision of Pulmonary and Critical Care Medicine, Mayo Clinic College of Medicine, Rochester, MN; and.
Lawrence M WeissClarient Pathology Services, Aliso Viejo, CA.
Histiocyte Society
Karolinska University Hospital · SEMemorial Sloan Kettering Cancer Center · USSorbonne Université · FRUniversité Paris-Saclay · FRUniversity of Toronto · CABrigham and Women's Hospital · USChildren's Cancer Center · USChildren's Hospital of Pittsburgh · USCincinnati Children's Hospital Medical Center · USDana-Farber Cancer Institute · USDélégation Paris 5 · FRHôpital Necker-Enfants Malades · FRHôpital Saint-Louis · FRHospital General Universitario Gregorio Marañón · ESHospital Universitario Fundación Jiménez Díaz · ESIcahn School of Medicine at Mount Sinai · USMayo Clinic · USThe University of Texas MD Anderson Cancer Center · US

Funding

Tissue ResourceP50CA126752 · NCI · BAYLOR COLLEGE OF MEDICINE · PI MALCOLM K. BRENNER, HELEN E HESLOP · 2007 to 2026
$51.4M
ERK control of Dendritic Cell Differentiation, Homeostasis and DiseaseR01CA154947 · NCI · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI CARL E ALLEN, MIRIAM MERAD · 2011 to 2026
$7.0M
NCI NIH HHS P50 CA126752NCI NIH HHS R01 CA154947
6 · The paper itself

Abstract

The histiocytoses are rare disorders characterized by the accumulation of macrophage, dendritic cell, or monocyte-derived cells in various tissues and organs of children and adults. More than 100 different subtypes have been described, with a wide range of clinical manifestations, presentations, and histologies. Since the first classification in 1987, a number of new findings regarding the cellular origins, molecular pathology, and clinical features of histiocytic disorders have been identified. We propose herein a revision of the classification of histiocytoses based on histology, phenotype, molecular alterations, and clinical and imaging characteristics. This revised classification system consists of 5 groups of diseases: (1) Langerhans-related, (2) cutaneous and mucocutaneous, and (3) malignant histiocytoses as well as (4) Rosai-Dorfman disease and (5) hemophagocytic lymphohistiocytosis and macrophage activation syndrome. Herein, we provide guidelines and recommendations for diagnoses of these disorders.

Indexed as

Dendritic CellsHistiocytic Disorders, MalignantHistiocytosis, Langerhans-CellHistiocytosis, Non-Langerhans-CellMacrophagesAdultFemaleHumansMale

Identifiers

PMID26966089
PMCPMC5161007
OpenAlexW2295097092

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.